Rubric :   Letter to editor

2526_330Suboptimal molecular response to tyrosine kinase inhibition associated with acquisition of a T240A ABL1 kinase domain mutation in a patient with chronic myeloid leukemia
Authors :Langabeer S.E.* Haslam K. Crampe M. MacDonagh B.... Date: 2019-03-26 / Views: 296
The JAK2 V617F mutation in lung cancer: caveat emptor
Author :Langabeer S.E.* Date: 2018-12-27 / Views: 384
Anagrelide and the CALR mutation allele burden in essential thrombocythemia
Authors :Atkinson E. Bakri M. Hayat A. Langabeer S.E.* Date: 2018-06-27 / Views: 372
Paraganglioma-like dermal melanocytic tumor: a rare skin lesionParaganglioma-like dermal melanocytic tumor: a rare skin lesion
Authors :Zinovkin D.A. Aliaksinski V.S. Hryb A.K. Dedik S.Yu. Vol. 37, No. 2 / Views: 481
Ukrain and its emerging role as an antineoplastic agent in systemic malignancies
Author :Kapoor S. Vol. 35, No. 2 / Views: 235
Vitamin C: attenuating effect on growth and proliferation in systemic malignancies
Author :Kapoor S. Vol. 35, No. 1 / Views: 360
THE COMPARASION OF CARCINOGENIC AND MUTAGENIC ACTION OF 7,12-DIMETHYLBENZO(a)ANTHRACENE IN THREE SPECIES OF RODENTS
Authors :Nersesyan A.K. Kaiser Hans E. Vol. 24, No. 4 / Views: 70
HCV AND RENAL CELL CARCINOMA: A NEW INSIGHT BETWEEN HCV AND ONCOGENESIS? REPORT OF FIVE CASES
Vol. 25, No. 1 / Views: 61
ANALYTICAL CHEMICAL CONSIDERATIONS ON TUMOR GENESIS
Author :Campanella L. 1 / Views: 59
IMPLICATION OF PROTOCADHERIN-PC IN THE PROGRESSION OF THE ADVANCED PROSTATE CANCER
Authors :Giannakopoulos X. Stagikas D. Peschos D. Batistatou A.... Vol. 29, No. 1 / Views: 76
LETTER TO EDITOR
Vol. 23, No. 2 / Views: 99
NATURAL ANTIBODIES TO ENDOTOXIN IN EXPERIMENTAL AND CLINICAL ONCOLOGY
Authors :Monceviciute-Eringiene E. Kazbariene B. Milasiene V. Characiejus D.... 1 / Views: 67
RETHINKING ANTICANCER SCREENING STRATEGIES SAVING LIVES AT FRONT LINE. RESULTS FROM SESY_EUROPE TASK FORCE
Authors :Mauri D. Kamposioras K. Polyzos N.P. Flores F.J. Rivas... Vol. 28, No. 3 / Views: 86
GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF): A NOVEL ANTICANCER THERAPY BASED ON THE “UNIVERSAL DYNAMICS OF TUMOR GROWTH”?
Author :Lopez-Lazaro M. 3 / Views: 76
Are monosomies underestimated while analyzing cancer cells?
Author :Tarkan-Argden Y. 4 / Views: 38